|
|
||||||||
From the Department of Neurology (Drs. Iwasa and Komai), Kanazawa University School of Medicine, Kanazawa; Neurological Center (Dr. Takamori), Kanazawa-Nishi Hospital, Kanazawa; and the Department of Information Physiology (Dr. Mori), National Institute for Physiological Sciences, Okazaki, Japan.
Address correspondence and reprint requests to Dr. Masaharu Takamori, Neurological Center, Kanazawa-Nishi Hospital, 77, Ko, Kita-machi, Kanazawa, Ishikawa 920-0055 Japan.
The authors studied sera from 36 patients with LambertEaton myasthenic syndrome (LEMS) by immunoblots using the recombinant protein derived from the DNA sequence encoding for the domain III S5-S6 linker of the P/Q-type voltage-gated calcium channel
1 subunit. The results of 18 patients were positive for antibodies to this recombinant protein. The results of 2 of 10 patients with lung cancer without LEMS were also positive.
Key words: LambertEaton myasthenic syndromeNeuromuscular transmissionP/Q-type voltage-gated calcium channelAutoimmunitySmall-cell lung carcinoma
This article has been cited by other articles:
![]() |
Y. J. Liao, P. Safa, Y.-R. Chen, R. A. Sobel, E. S. Boyden, and R. W. Tsien Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo PNAS, February 19, 2008; 105(7): 2705 - 2710. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |